All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YJ417 | Anti-TUBA8 (2E9) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2E9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ418 | Anti-TUBA8 (3E10) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 3E10 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ419 | Anti-TUBA8 (3G2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 3G2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ420 | Anti-TUBA8 (2G6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Dog, Monkey, Rat | 2G6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ421 | Anti-TUBA8 (2C2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Monkey | 2C2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ422 | Anti-TUBA8 (2D6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Rat | 2D6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ917 | Anti-TUBA8 (2E9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2E9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ918 | Anti-TUBA8 (3E10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3E10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ919 | Anti-TUBA8 (3G2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3G2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ920 | Anti-TUBA8 (2G6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Dog, Monkey, Rat | 2G6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ921 | Anti-TUBA8 (2C2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Monkey | 2C2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ922 | Anti-TUBA8 (2D6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Rat | 2D6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION